Cognitive impairment in the preclinical stage of dementia in FTD-3 CHMP2B mutation carriers: a longitudinal prospective study

Jette Stokholm; Thomas W Teasdale; Peter Johannsen; Jorgen E Nielsen; Troels Tolstrup Nielsen; Adrian Isaacs; Jerry M Brown; Anders Gade

doi:10.1136/jnnp-2012-303813

Article info

Neurodegeneration

Research paper

Cognitive impairment in the preclinical stage of dementia in FTD-3 CHMP2B mutation carriers: a longitudinal prospective study

Authors

Jette Stokholm Memory Disorders Research Group, Department of Neurology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark PubMed articles Google scholar articles
Thomas W Teasdale Department of Psychology, University of Copenhagen, Copenhagen, Denmark PubMed articles Google scholar articles
Peter Johannsen Memory Disorders Research Group, Department of Neurology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark PubMed articles Google scholar articles
Jorgen E Nielsen Memory Disorders Research Group, Department of Neurology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, DenmarkSection of Neurogenetics, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark PubMed articles Google scholar articles
Troels Tolstrup Nielsen Memory Disorders Research Group, Department of Neurology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, DenmarkSection of Neurogenetics, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark PubMed articles Google scholar articles
Adrian Isaacs Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK PubMed articles Google scholar articles
Jerry M Brown Department of Neurology, Addenbrooke's Hospital, Cambridge, UK PubMed articles Google scholar articles
Anders Gade Department of Psychology, University of Copenhagen, Copenhagen, Denmark PubMed articles Google scholar articles

Correspondence to Jette Stokholm, Memory Disorders Research Group, Department of Neurology, Rigshospitalet, Copenhagen University Hospital, N6702, 9 Blegdamsvej, Copenhagen 2100, Denmark; jette.stokholm{at}rh.regionh.dk

View Full Text

Citation

Stokholm J, Teasdale TW, Johannsen P, et al

Cognitive impairment in the preclinical stage of dementia in FTD-3 CHMP2B mutation carriers: a longitudinal prospective study

Journal of Neurology, Neurosurgery & Psychiatry 2013;84:170-176.

Publication history

Received August 2, 2012
Revised October 11, 2012
Accepted October 13, 2012
First published November 10, 2012.

Online issue publication

April 13, 2016

Article Versions

Previous version (13 April 2016).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password